首页> 外文OA文献 >National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.

【2h】

National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.

机译：美国国家临床生物化学研究院实验室医学在睾丸癌，前列腺癌，结肠直肠癌，乳腺癌和卵巢癌中使用肿瘤标志物的实践指南。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Sturgeon CM; Duffy MJ; Stenman UH; Lilja H; Brünner N; Chan DW; Babaian R; Bast RC; Dowell B; Esteva FJ; Haglund C; Harbeck N; Hayes DF; Holten-Andersen M; Klee GG; Lamerz R; Looijenga LH; Molina R; Nielsen HJ; Rittenhouse H; Semjonow A; Shih I; Sibley P; Sölétormos G; Stephan C; Sokoll L; Hoffman BR; Diamandis EP;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers [J] . Axel Semjonow, Barry Dowell, Barry R. Hoffman, Clinical Chemistry: Journal of the American Association for Clinical Chemists . 2008,第12期

机译：美国国家临床生物化学研究院实验室医学在睾丸癌，前列腺癌，结直肠癌，乳腺癌和卵巢癌中使用肿瘤标志物的实践指南
2. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Clinical Practice: Quality Requirements [J] . Barry R. Hoffman, Catharine M. Sturgeon, Daniel F. Hayes, Clinical Chemistry: Journal of the American Association for Clinical Chemists . 2008,第8期

机译：美国国家临床生物化学研究院实验室医学实践指南中使用肿瘤标记物的质量要求
3. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers [J] . Catharine M Sturgeon Michael J Duffy Barry R Hofmann Rolf Lamerz Herbert A Fritsche Katja Gaarenstroom Johannes Bonfrer Thorsten H Ecke H Barton Grossman Peter Hayes Ralf-Thorsten Hoffmann Seth P Lerner Florian Löhe Johanna Louhimo Clinical Chemistry . 2010,第6期

机译：美国国家生物化学临床化学实验室医学实践指南在肝癌，膀胱癌，宫颈癌和胃癌中使用肿瘤标志物
4. Underscoring Markers that Distinguish Ovarian, Breast, Prostate and Lung Cancer using Microarrays [C] . Peter Tolias Chips to Hits . 2002

机译：强调使用微阵列区分卵巢癌，乳腺癌，前列腺癌和肺癌的标志物
5. Tumor-specific loss of human kallikrein 10 (KLK10/NES-1) by CpG island hypermethylation in breast, ovarian and prostate cancers. [D] . Sidiropoulos, Michael. 2003

机译：CpG岛超甲基化在乳腺癌，卵巢癌和前列腺癌中对人类激肽释放酶10（KLK10 / NES-1）的肿瘤特异性丧失。
6. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Clinical Practice: Quality Requirements [O] . Catharine M. Sturgeon, Barry R. Hoffman, Daniel W. Chan, -1

机译：美国国家临床生物化学研究院实验室医学实践指南中使用肿瘤标记物的质量要求
7. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical Issues for Biochemical Markers of Acute Coronary Syndromes [O] . F. S. Apple, R. L. Jesse, L. K. Newby, 2007

机译：国家临床生物化学学会和IFCC委员会的心脏损伤实验室实践标志标志性标志性指南：急性冠状动脉综合征的生化标志性分析问题

National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.

著录项

引文网络

相似文献

相关主题

期刊订阅